IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex Reports Fall in Fourth-Quarter Profits

12:09 AM MST | February 8, 2012 | Deepti Ramesh

Cambrex (East Rutherford, NJ) reported an 84% fall in net profits for the fourth quarter ended December 31, 2011, compared with the year-ago quarter, to $741,000. Net sales for the quarter increased 5.3%, to $66.58 million. For the full year 2011, net profits increased nearly 14%, to $10.96 million. Full-year net sales increased 12.3%, to about $252.7 million. The increase in fourth-quarter sales is primarily due to increased demand for an active pharmaceutical ingredient (API) manufactured under a long-term supply agreement, a recently approved innovator...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa